Reaching an unprecedented peak during COVID-19, demand for patient-centric services continues to grow as sponsors seek more flexible, cost-effective ways to support trial enrollment and retention.

Marken is helping reshape clinical research by easing the burden on both participants and investigator sites through a comprehensive suite of patient-focused solutions.

In this featured video, Robin Marcus, head of global decentralized trials market development at Marken, UPS Healthcare Precision Logistics, highlights how services such as home healthcare visits, central pharmacy, and direct-to-patient logistics are expanding trial access and improving flexibility.

Marken delivers a competitive edge through its unwavering commitment to quality, deep site relationships, and unique ability to integrate mobile clinical care with precision logistics. Marken is also expanding its site augmentation services, supporting the unique demands of cell and gene therapy and nuclear medicine trials, and driving initiatives to improve patient representation in clinical research

Watch the dynamic video below to explore Marken’s innovative roadmap and what’s next in decentralized and hybrid trials.